NuCana (NCNA) EBITDA (2017 - 2025)

NuCana has disclosed EBITDA across 9 years of filings, most recently posting -$3.7 million for Q4 2025.

• EBITDA for Q4 2025 came in at -$3.7 million, down 235.47% year-over-year; the trailing twelve-month figure through Dec 2025 was -$39.5 million (down 60.87% YoY), and the FY2025 annual result was -$26.5 million, up 9.06% from the prior year.
• EBITDA came in at -$3.7 million for Q4 2025 at NuCana, down from -$360279.7 in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$360279.7 in Q3 2025 to a low of -$32.2 million in Q2 2025.
• The 5-year median for EBITDA is -$8.7 million (2024), against an average of -$10.0 million.
• Peak annual rise in EBITDA reached 93.92% in 2025, while the deepest fall reached 265.09% in 2025.
• NuCana's EBITDA stood at -$21.2 million in 2021, then increased by 4.63% to -$20.2 million in 2022, then jumped by 44.13% to -$11.3 million in 2023, then surged by 90.18% to -$1.1 million in 2024, then slumped by 235.47% to -$3.7 million in 2025.
• The last three EBITDA figures came in at -$3.7 million (Q4 2025), -$360279.7 (Q3 2025), and -$32.2 million (Q2 2025), per Business Quant data.